1. Use of the 445-nm Blue Laser for Management of Early Glottic Carcinoma: Preliminary 1-Year Results.
- Author
-
Rosow DE, Keidar E, Pasick LJ, Casellas NJ, and Anis MM
- Subjects
- Humans, Male, Female, Retrospective Studies, Middle Aged, Aged, Treatment Outcome, Laryngoscopy methods, Follow-Up Studies, Aged, 80 and over, Adult, Voice Quality, Laryngeal Neoplasms surgery, Laryngeal Neoplasms mortality, Laryngeal Neoplasms pathology, Laryngeal Neoplasms radiotherapy, Glottis surgery, Glottis pathology, Lasers, Solid-State therapeutic use, Laser Therapy methods
- Abstract
Objective: To analyze oncological efficacy and voice outcomes of the 445-nm blue laser (BL) in the treatment of early glottic carcinoma and compare results with the 532-nm potassium-titanyl-phosphate (KTP) laser., Study Design: Single institution, retrospective chart review., Methods: All patients who underwent microlaryngoscopic KTP or BL laser excision of early glottic carcinoma from 2018 to the present day with at least 1-year follow-up were included. Primary and recurrent disease, including radiation and surgical failures, were included. Demographic data, voice outcomes and oncologic outcomes were compared between the two laser groups., Results: Forty-nine patients met the inclusion criteria for the BL group and 88 for the KTP group, with average follow-up of 635 and 1236 days, respectively. Oncologic outcomes were not significantly different, with disease-specific survival rates of 95.9% for BL and 100% for KTP (p = 0.13), organ preservation rates of 98.0% for BL and 95.6% for KTP (p = 0.39), and local control rates of 93.9% for BL and 92.1% for KTP (p = 0.81). Both BL and KTP groups showed significant improvement in CAPE-V (p = 0.04, 0.006 respectively) and VHI-10 scores (p = 0.003, <0.00001) following surgery., Conclusions: Photoangiolytic removal of early glottic carcinoma with BL appears to be equally safe and effective as with KTP laser at minimum one-year follow-up, and with excellent voice outcomes. Additional study will be warranted over time to assess long-term outcomes in BL patients., Level of Evidence: 3 Laryngoscope, 134:4656-4660, 2024., (© 2024 The Author(s). The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2024
- Full Text
- View/download PDF